()-N6-(2-Phenylisopropyl)adenosine
| Catalog number: | B2023728 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 25 mg |
| Molecular Weight or Concentration: | 385.42 |
| Supplied as: | Powder |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 2-8C |
| Keywords: | (R)-N6-(1-Methyl-2-phenylethyl)adenosine, N6-(L-2-Phenylisopropyl)adenosine, R-()-PIA |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Klotz, K. N., & Schmid, C. (2000). The role of adenosine receptors in the cardiovascular system. *Cardiovascular Research*, 48(1), 1-10.
- Fredholm, B. B., et al. (2001). Adenosine and regulation of the cardiovascular system. *Pharmacological Reviews*, 53(4), 527-552.
- Burnstock, G. (2007). Physiology and pathophysiology of purinergic signaling. *Physiological Reviews*, 87(2), 659-697.
- Jacobson, K. A., & Gao, Z. G. (2006). Adenosine receptors as therapeutic targets. *Nature Reviews Drug Discovery*, 5(3), 247-264.
- Hask, G., et al. (2008). Adenosine receptors: therapeutic aspects for inflammatory diseases. *Expert Opinion on Therapeutic Targets*, 12(12), 1431-1440.
- Ralevic, V., & Burnstock, G. (1998). Receptors for purines and pyrimidines. *Pharmacological Reviews*, 50(3), 413-492.
- Borea, P. A., et al. (2018). The role of adenosine receptors in the regulation of the immune system. *Frontiers in Immunology*, 9, 1-12.
- Chen, J. F., et al. (2013). Adenosine receptors and neuroprotection. *Neuropharmacology*, 67, 1-10.
- Ruan, H., et al. (2015). The role of adenosine in the regulation of inflammation and immunity. *Nature Reviews Immunology*, 15(12), 823-835.
- Liao, J. K., & Wang, D. (2015). The role of adenosine in cardiovascular disease. *Nature Reviews Cardiology*, 12(12), 703-711.
